6 clinical trials found.
-
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
CAPTIVA is a two-stage Phase III trial randomizing subjects with stroke attributed to 70-99% intracranial atherosclerotic stenosis (sICAS) to 12 months treatment of: 1) ticagrelor ...Phase
TRIAL ROLE: Principal Investigator
-
Neurological Emergencies Outcomes at NYU
The purpose of this submission is to establish risk factors for infection after acute neurologic injury and to determine their impact on long-term outcomes. The ...Phase N/A TRIAL ROLE: Sub Investigator
-
STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)
This is a multi-center, pragmatic, prospective, randomized, open-label, and blinded end-point assessment (PROBE) clinical trial. A total of 1,456 patients presenting within 7 days ...Phase
TRIAL ROLE: Sub Investigator
-
Anticoagulation for Stroke Prevention and Recovery after ICH (ASPIRE)
Survivors of intracerebral hemorrhage (ICH) who have atrial fibrillation/flutter (AF) are at high risk for subsequent ischemic stroke. Although randomized clinical trials have established ...Phase
TRIAL ROLE: Sub Investigator
-
SleepSMART: Sleep for Stroke Management And Recovery Trial
Investigator-initiated, phase 3 multicenter, prospective randomized open-, blinded-endpoint (PROBE) controlled trial to test whether treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure ...Phase
TRIAL ROLE: Sub Investigator
-
Biomarker and Edema Attenuation in IntraCerebral hemorrhage (BEACH)
This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH). This study ...Phase
TRIAL ROLE: Sub Investigator
